Paperpal Prime Logo

Diabetes and Metabolism Journal : Impact Factor & More

eISSN: 2233-6087pISSN: 2233-6079
JournalOpen Access

Key Metrics

CiteScore
7.9
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SJR
Q2Endocrinology, Diabetes and Metabolism
SNIP
1.58
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Diabetes and Metabolism Journal

Diabetes and Metabolism Journal Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher KOREAN DIABETES ASSOC
Language English
Frequency Bi-monthly
Article Processing ChargesUSD 500
Publication Time52
Editorial Review ProcessPeer review
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1972
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
Publication Time 52
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessPeer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Diabetes and Metabolism Journal ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Diabetes and Metabolism Journal

Glucose-Independent Metabolic Signatures of SGLT2 Inhibition in Diabetic Kidney Disease: Integrated Insights from Mendelian Randomization and Transcriptomics.
  • 7 Aug 2026
  • Diabetes & metabolism journal
FAM151A Regulates Insulin Secretion in Pancreatic β-Cells and Is Implicated in Pathogenesis of Type 2 Diabetes Mellitus.
  • 6 Aug 2026
  • Diabetes & metabolism journal
4-Octyl Itaconate Promotes Diabetic Wound Healing by Enhancing Pro-Resolving Macrophages via the Efferocytosis-MCT1-Lactate-GPR132 Pathway and Macrophage-Independent Synergistic Effects.
  • 5 Aug 2026
  • Diabetes & metabolism journal
Efficacy and Safety of the Dual SGLT1 and SGLT2 Inhibitor JP-2266 in Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study.
  • 29 Jul 2026
  • Diabetes & metabolism journal
Semaglutide and Exercise Synergy in Obesity: Preserving Muscle Mass and Uncovering Organ Crosstalk.
  • 15 Jul 2026
  • Diabetes & metabolism journal
4-Octyl Itaconate Promotes Diabetic Wound Healing by Enhancing Pro-Resolving Macrophages via the Efferocytosis-MCT1-Lactate-GPR132 Pathway and Macrophage-Independent Synergistic Effects (Diabetes Metab J 2026;50:707-23).
  • 1 Jul 2026
  • Diabetes & metabolism journal
Glucose-Independent Metabolic Signatures of SGLT2 Inhibition in Diabetic Kidney Disease: Integrated Insights from Mendelian Randomization and Transcriptomics.
  • 7 Aug 2026
  • Diabetes & metabolism journal
FAM151A Regulates Insulin Secretion in Pancreatic β-Cells and Is Implicated in Pathogenesis of Type 2 Diabetes Mellitus.
  • 6 Aug 2026
  • Diabetes & metabolism journal
4-Octyl Itaconate Promotes Diabetic Wound Healing by Enhancing Pro-Resolving Macrophages via the Efferocytosis-MCT1-Lactate-GPR132 Pathway and Macrophage-Independent Synergistic Effects.
  • 5 Aug 2026
  • Diabetes & metabolism journal
Efficacy and Safety of the Dual SGLT1 and SGLT2 Inhibitor JP-2266 in Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study.
  • 29 Jul 2026
  • Diabetes & metabolism journal
Semaglutide and Exercise Synergy in Obesity: Preserving Muscle Mass and Uncovering Organ Crosstalk.
  • 15 Jul 2026
  • Diabetes & metabolism journal
4-Octyl Itaconate Promotes Diabetic Wound Healing by Enhancing Pro-Resolving Macrophages via the Efferocytosis-MCT1-Lactate-GPR132 Pathway and Macrophage-Independent Synergistic Effects (Diabetes Metab J 2026;50:707-23).
  • 1 Jul 2026
  • Diabetes & metabolism journal

FAQs on Diabetes and Metabolism Journal